Search

everythinglearnresearchcommunity

for

Search:↓

The Endocrine Society advised against routine testosterone therapy for women, citing a need for more research on long-term safety and a clear definition of androgen deficiency.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The Rotterdam Study updated its design and objectives in 2012, providing insights into various diseases in the elderly, including skin cancer, bone health, liver disease, neurological and psychiatric conditions, and respiratory issues.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Finasteride doesn't effectively treat hair loss in postmenopausal women.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Guidelines suggest various treatments for alopecia areata, but leaving it untreated is also an option as 80% cases may recover on their own.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Interferon alfa-2a is effective for treating cutaneous T cell lymphoma but has significant side effects.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Male hormones, particularly DHT, are linked to male pattern hair loss, and treatments like finasteride can help, but they don't work for postmenopausal women's hair loss, which may have different causes.

Chemotherapy-induced hair loss significantly affects patients' well-being, and nurses are key in helping them cope, but more research is needed to find effective treatments.

Humans lost body hair relatively recently in evolution.

Cancer cells often have more copies of TERT and TERC genes, which helps them grow and could affect patient outcomes.

K_ATP channel gene mutations are linked to heart diseases, but more research is needed to understand the connection and treatment potential.

Postpartum depression is linked to changes in brain chemicals, inflammation, stress, and certain genes, and can potentially be identified by markers like specific steroids, serotonin levels, and vitamin D levels.

Stem cell plasticity is crucial for wound healing but can also contribute to cancer development.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

We need more research to better understand human hair follicle stem cells for improved treatments for hair loss and skin cancer.

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

Different soft tissue fillers can cause various skin reactions; biodegradable fillers are safer and non-biodegradable ones like silicone can lead to long-term problems.

Treatments for permanent hair loss from scarring aim to stop further loss, not regrow hair, and vary by condition, with partial success common.

A new gene mutation causes female pseudohermaphroditism due to glucocorticoid resistance.

White lupin uses specific genes to grow root hairs and access phosphorus when it's scarce.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Japanese women typically start experiencing hair loss after 40, with reduced hair density and thickness being the main factors.

Keratin proteins are crucial for healthy skin, but mutations can cause skin disorders with no effective treatments yet.